|
A combination picture shows a faulty interceptor missile launched by Israel’s Iron Dome anti-missile system disintegrating above southern Lebanon. REUTERS/Amir Cohen
|
|
|
|
|
- In a landmark deal, Paramount is poised to acquire Warner Bros. and gain the studio’s extensive catalog and history. The deal, expected to close in late summer this year, will reshape the industry. Our graphics team takes a closer look.
- The Trump administration has proposed new tariffs of 10% and 12.5% on imports from 60 economies after determining that they failed to curb trade in goods made with forced labor, a finding described by a senior EU lawmaker as "utterly absurd".
- SpaceX and Anthropic are preparing for what may be the biggest public-market launches in U.S. history, with OpenAI rumored to be close behind. What happens when IPOs go wrong?
- Microsoft announced a sweeping slate of AI initiatives, from autonomous workplace assistants and gadgets to Nvidia-powered PCs and a new in-house reasoning model, in a push to move beyond apps and remake computing around AI.
- A US jury's fraud conviction of prominent investor Andrew Left this week could rewrite the playbook for activist short sellers, raising fresh questions about the line between legitimate market activism and stock manipulation.
|
|
|
|
|
Cathy Smithwick stands in Northern California garden, California, U.S., April 29, 2026. Cathy Smithwick/Handout via REUTERS
|
Cathy Smithwick, now 67, has lived with breast cancer, and then ovarian cancer, for more than 20 years with the help of targeted drugs, drugs that harness the body's immune system, chemotherapy and hormone pills.
Michelle Vacca, who recently turned 59, has had lung cancer for nearly 10 years and is doing well on an experimental drug that targets a rare tumor mutation.
Both are among a growing number of Americans living with cancer as scientists continue to unravel the biological underpinnings of the disease and develop new drugs that target a tumor's genetic signature.
|
|
|
|
Nicholas Galitzine attends the Los Angeles world premiere for ''Masters of the Universe'' at The Egyptian Theatre Hollywood. REUTERS/Aude Guerrucci
|
While Nicholas Galitzine, star of the 2026 fantasy film "Masters of the Universe," didn’t grow up playing with the classic Mattel He-Man toys or watching the 1983 animated series, he found his own way to connect with the role.
|
|
|
|
|
|
| |
|
|
Reuters Daily Briefing is sent 5 days a week. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here. Want to stop receiving this email? Unsubscribe here. To manage which newsletters you're signed up for, click here. This email includes limited tracking for Reuters to understand whether you’ve engaged with its contents. For more information on how we process your personal information and your rights, please see our Privacy Statement. Terms & Conditions |
|
| |
© 2026 Thomson Reuters. All rights reserved.
3 Times Square, New York, NY 10036 |
|
|
|
|
|
